Advanced ScienceEfficient topical drug delivery remains a significant challenge in glaucoma management. Although nanoparticle formulations offer considerable promise, their complex preparation processes, co‐delivery issues, and batch consistency have hindered their ...
Da Huang +8 more
doaj +1 more source
Comparative analysis of PLGA ocuserts of brimonidine tartrate prepared with different methods
European Pharmaceutical JournalThe eye is a highly sensitive organ with multiple physiological barriers that limit drug bioavailability and reduce patient compliance. Research studies are still going on to discover a novel drug delivery system for ocular delivery. The current research
Paramjot +4 more
doaj +1 more source
Effect of brimonidine tartrate 0.15% on scotopic pupil size and upper eyelid position: controlled trial. [PDF]
Eye (Lond), 2021 Tuncer I +6 more
europepmc +1 more source
Clinical Ophthalmology, 2013 Elad Moisseiev, Shimon Kurtz, Moshe Lazar, Gabi ShemeshDepartment of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelBackground: The purpose of this study was to evaluate the safety and efficacy of a fixed combination of timolol maleate ...
Moisseiev E, Kurtz S, Lazar M, Shemesh G
doaj
Yuvezzi™ (carbachol and brimonidine tartrate) dual-agent eyedrops: a new option for presbyopia. [PDF]
Ann Med Surg (Lond)Abid MA, Abid MH, Afzal MD.
europepmc +1 more source
Engineered Brimonidine Tartrate Aminosomes as a Mucoadhesive Platform for Sustained Glaucoma Management: Optimization, In Vitro Characterization, and In Vivo Evaluation. [PDF]
PharmaceuticsOmar WM +4 more
europepmc +1 more source
Effects of Ripasudil Hydrochloride Hydrate-Brimonidine Tartrate Fixed-Dose Combination Using Rho Kinase Inhibitor and Alpha2 Adrenergic Receptor Agonist on Aqueous Column in the Episcleral Vein: A Randomized, Double-Masked, Crossover Clinical Trial (ROCK Alpha-Aqua Study). [PDF]
J Clin MedSuzuki M +7 more
europepmc +1 more source